Search - tctmd.com

Displaying 81 - 100 of 148

Sort: Relevancy | Date

Presentation EuroPCR 2017

Efficacy and Safety of LAA Closure with WATCHMAN in Patients with or without Contraindication to Oral Anticoagulation: 1-year FU of the EWOLUTION trial

Presenter: Lucas Boersma, Martin W. Bergmann

May 18, 2017

Presentation EuroPCR 2017

Safety of Coronary Revascularisation Deferral Based on iFR and FFR Measurements in Stable Angina and Acute Coronary Syndromes

Presenter: Javier Escaned

May 17, 2017

Presentation EuroPCR 2017

1-year Outcomes of Transcatheter Mitral Valve Replacement in Native Mitral Valve Disease With Severe Mitral Annular Calcification

Presenter: Mayra Guerrero

May 17, 2017

Aspirin Versus Aspirin Plus Clopidogrel as Antithrombotic Treatment Following Transcatheter Aortic Valve Replacement With a Balloon-Expandable Valve The ARTE Randomized Clinical Trial

Presentation EuroPCR 2017

The ARTE Randomized Clinical Trial

Presenter: Josep Rodés-Cabau

May 17, 2017

Presentation EuroPCR 2017

ABSORB Japan Results: 3-year Clinical and Angiographic Results

Presenter: Ken Kozuma

May 17, 2017

Presentation EuroPCR 2017

Randomized Comparison of Everolimus-eluting Bioresorbable Vascular Scaffolds vs. Everolimus-eluting Metallic Stents in Patients with Coronary Artery Disease: 3-year Clinical Outcomes from ABSORB China

Presenter: Runlin Gao

May 17, 2017

Presentation EuroPCR 2017

Final five-year Clinical and Echocardiographic Results of Treatment for Severe Aortic Stenosis with a Self-Expanding Bioprosthesis from the ADVANCE Study

Presenter: Ulrich Gerckens

May 17, 2017

Presentation EuroPCR 2017

A Prospective, Randomised Investigation of a Novel Transcatheter Aortic Valve Implantation System: The REPRISE III Trial

Presenter: Ted E. Feldman

May 16, 2017

Presentation EuroPCR 2016

Radial versus femoral access in patients with acute coronary syndromes with or without ST-segment elevation

Presenter: Bernando Cortese

May 23, 2016

Presentation EuroPCR 2016

LAA Occlusion vs Standard Care In Patients With Atrial Fibrillation And Intracerebral Hemorrhage

Presenter: Jens Erik Nielsen-Kudsk

May 20, 2016

Presentation EuroPCR 2016

Early Percutaneous Intervention for Valvular Disease …An Opportunity for Improving Patient’s Outcome

Presenter: Patrick Serruys

May 20, 2016

Presentation EuroPCR 2016

A Patient Level Pooled Analysis of NeuroProtection with the TriGuard Embolic DEFLECTion Device Compared to Unprotected Transcatheter Aortic Valve Replacement

Presenter: Alexandra Lansky

May 20, 2016

Presentation EuroPCR 2016

Sealing Moderate Coronary Saphenous Vein Graft Lesions with Drug-Eluting Stents as a New Approach to Reducing Cardiac Events The VELETI II Randomized Trial

Presenter: Josep Rod?s-Cabau

May 19, 2016

Presentation EuroPCR 2016

Impact of Coronary Artery Disease on Clinical Outcomes Among Patients Undergoing Transcatheter Aortic Valve Implantation: An Age- and Sex-Matched Cohort Study

Presenter: Anna Franzone

May 19, 2016

Presentation EuroPCR 2016

First Look at Long-term Durability of Transcatheter Heart Valves: Assessment of Valve Function up To 10-years After Implantation

Presenter: Danny Dvir

May 19, 2016

Presentation EuroPCR 2016

Biolimus-A9 polymer-free coated stent in high bleeding risk patients with acute coronary syndrome: a LEADERS FREE ACS substudy

Presenter: Christoph Naber

May 19, 2016

Presentation EuroPCR 2016

Transcatheter Mitral Valve Replacement in Native Mitral Valve Disease with Severe Mitral Annular Calcification

Presenter: Mayra Guerrero

May 18, 2016

Presentation EuroPCR 2016

EWOLUTION: 3-months outcome of Left Atrial Appendage Closure with the WATCHMAN device in Europe

Presenter: Martin Bergmann

May 18, 2016

Presentation EuroPCR 2016

Effect of DAPT Termination at 12 Months on Very Late scaffold thrombosis in regular clinical practice: Data of a regional collaboration

Presenter: Robert-Jan van Geuns

May 18, 2016

Presentation EuroPCR 2016

A Randomised Comparison Between Drug-Eluting Balloon and Conventional Balloon Angioplasty for Lesions in The Penile Artery in Patients With Erectile Dysfunction: The PEFECT-4 Study

Presenter: Tzung-Dau Wang

May 18, 2016

Advertisement

Efficacy and Safety of LAA Closure with WATCHMAN in Patients with or without Contraindication to Oral Anticoagulation: 1-year FU of the EWOLUTION trial

Safety of Coronary Revascularisation Deferral Based on iFR and FFR Measurements in Stable Angina and Acute Coronary Syndromes

1-year Outcomes of Transcatheter Mitral Valve Replacement in Native Mitral Valve Disease With Severe Mitral Annular Calcification

The ARTE Randomized Clinical Trial

ABSORB Japan Results: 3-year Clinical and Angiographic Results

Randomized Comparison of Everolimus-eluting Bioresorbable Vascular Scaffolds vs. Everolimus-eluting Metallic Stents in Patients with Coronary Artery Disease: 3-year Clinical Outcomes from ABSORB China

Final five-year Clinical and Echocardiographic Results of Treatment for Severe Aortic Stenosis with a Self-Expanding Bioprosthesis from the ADVANCE Study

A Prospective, Randomised Investigation of a Novel Transcatheter Aortic Valve Implantation System: The REPRISE III Trial

Radial versus femoral access in patients with acute coronary syndromes with or without ST-segment elevation

LAA Occlusion vs Standard Care In Patients With Atrial Fibrillation And Intracerebral Hemorrhage

Early Percutaneous Intervention for Valvular Disease …An Opportunity for Improving Patient’s Outcome

A Patient Level Pooled Analysis of NeuroProtection with the TriGuard Embolic DEFLECTion Device Compared to Unprotected Transcatheter Aortic Valve Replacement

Sealing Moderate Coronary Saphenous Vein Graft Lesions with Drug-Eluting Stents as a New Approach to Reducing Cardiac Events The VELETI II Randomized Trial

Impact of Coronary Artery Disease on Clinical Outcomes Among Patients Undergoing Transcatheter Aortic Valve Implantation: An Age- and Sex-Matched Cohort Study

First Look at Long-term Durability of Transcatheter Heart Valves: Assessment of Valve Function up To 10-years After Implantation

Biolimus-A9 polymer-free coated stent in high bleeding risk patients with acute coronary syndrome: a LEADERS FREE ACS substudy

Transcatheter Mitral Valve Replacement in Native Mitral Valve Disease with Severe Mitral Annular Calcification

EWOLUTION: 3-months outcome of Left Atrial Appendage Closure with the WATCHMAN device in Europe

Effect of DAPT Termination at 12 Months on Very Late scaffold thrombosis in regular clinical practice: Data of a regional collaboration

A Randomised Comparison Between Drug-Eluting Balloon and Conventional Balloon Angioplasty for Lesions in The Penile Artery in Patients With Erectile Dysfunction: The PEFECT-4 Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content